McKesson Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by McKesson Corporation on January 13, 2022. The report discloses corporate governance changes regarding the Board of Directors effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on director elections and related compensation arrangements rather than financial performance.
Material Changes
The primary material change reported is the election of two new directors to the Board of Directors:
- James H. Hinton: Operating partner at Welsh, Carson, Anderson & Stone; former CEO of Baylor Scott & White Health.
- Kathleen Wilson-Thompson: Former Executive Vice President and Global Chief Human Resources Officer at Walgreens Boots Alliance.
The Board expects to appoint Mr. Hinton to the Compliance and Governance Committees, and Ms. Wilson-Thompson to the Compensation and Governance Committees.
Compensation and Governance Details
Both new directors will receive standard compensatory arrangements for non-employee directors:
- Cash Retainer: $80,000 annually, prorated based on the election date of January 13, 2022.
- Equity Award: Restricted Stock Units (RSUs) effective February 7, 2022. The number of units is calculated by dividing $94,191.78 by the closing stock price on February 7, 2022.
- Indemnification: Both directors entered into standard Indemnification Agreements effective January 13, 2022.
Investor Verification Checklist
- Verify the closing price of McKesson common stock on February 7, 2022, to calculate the exact number of RSUs granted.
- Confirm the official committee assignments for Mr. Hinton and Ms. Wilson-Thompson once formally appointed by the Board.
- Review the attached news release (Exhibit 99.1) for additional biographical details or context not included in the 8-K text.